Home/Filings/4/0001179110-19-006512
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-19-006512

CIK 0001292519other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:55 PM ET

Size

6.0 KB

Accession

0001179110-19-006512

Insider Transaction Report

Form 4
Period: 2019-05-20
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-05-20$1.10/sh78$8610,615 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,228
Footnotes (2)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 250 stock-settled RSUs.
  • [F2]Between January 1, 2018 and May 22, 2019, the reporting person acquired 5,228 shares of NVIV common stock under the NVIV 401(k) plan. The information in this report isbased on a plan statement dated as of May 22, 2019.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:55 PM ET
Size
6.0 KB